The primary goal of the Collaborative Opportunities Component (Collab-C) of this National Resource Center, the High-Impact Trials Center (HITC), is to provide research advice and, if needed, infrastructure to coordinate Phase I/II clinical trials for evidence based rehabilitation interventions, which can be moved efficiently into Phase III trials or assist in Phase III or IV trials. This will be achieved by accomplishing the following 6 specific aims:
Aim 1. Establish/maintain communications with the NIH P2C Program, this HITC, and medical rehabilitation teams across the US. We will work closely with Promo-C and the CCIT to support an interactive and intelligent website that provides education and resources to rehabilitation researchers.
Aim 2. Provide content, statistical expertise and support for the development or refinement of study questions and/or provide the statistical monitoring plans, adaptive trial scenarios, interim assessments and p analyses.
Aim 3. Offer standardized and successful mechanisms to ensure protocols are developed, operationalized rapidly, easily and reliably, with the appropriate partners in rehabilitation research.
Aim 4. Advise on data management systems that are flexible enough to allow study-specific modules, but complete enough for consistency across studies.
Aim 5. Advise on incorporation of mechanistic secondary outcomes as appropriate, and provide access to a comprehensive menu of HITC core facilities to complete these ancillary experiments at the HITC, or training to do so at the investigator's home institution or another P2C resource center.
Aim 6. Support analysis of pooled data across the multiple studies facilitated by Collab-C, for both scientific contributions to the literature as well as future study planning.
| Hower, Isabella M; Harper, Sara A; Buford, Thomas W (2018) Circadian Rhythms, Exercise, and Cardiovascular Health. J Circadian Rhythms 16:7 |
| Kelly, Neil A; Hammond, Kelley G; Stec, Michael J et al. (2018) Quantification and characterization of grouped type I myofibers in human aging. Muscle Nerve 57:E52-E59 |
| Roberts, Brandon M; Lavin, Kaleen M; Many, Gina M et al. (2018) Human neuromuscular aging: Sex differences revealed at the myocellular level. Exp Gerontol 106:116-124 |
| Demark-Wahnefried, Wendy; Schmitz, Kathryn H; Alfano, Catherine M et al. (2018) Weight management and physical activity throughout the cancer care continuum. CA Cancer J Clin 68:64-89 |
| Buford, Thomas W; Carter, Christy S; VanDerPol, William J et al. (2018) Composition and richness of the serum microbiome differ by age and link to systemic inflammation. Geroscience 40:257-268 |
| Murphy, Susan L; Barber, Mary Whitehouse; Homer, Kate et al. (2018) Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study. Arthritis Care Res (Hoboken) 70:1653-1660 |
| Sasaki, Jeffer Eidi; Sandroff, Brian; Bamman, Marcas et al. (2017) Motion sensors in multiple sclerosis: Narrative review and update of applications. Expert Rev Med Devices 14:891-900 |
| Stec, Michael J; Thalacker-Mercer, Anna; Mayhew, David L et al. (2017) Randomized, four-arm, dose-response clinical trial to optimize resistance exercise training for older adults with age-related muscle atrophy. Exp Gerontol 99:98-109 |
| Espay, Alberto J; Schwarzschild, Michael A; Tanner, Caroline M et al. (2017) Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials. Mov Disord 32:319-324 |
| Gerstenecker, Adam; Roberson, Erik D; Schellenberg, Gerard D et al. (2017) Genetic influences on cognition in progressive supranuclear palsy. Mov Disord 32:1764-1771 |
Showing the most recent 10 out of 11 publications
